NeuroBo Pharmaceuticals (NASDAQ:NRBO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NeuroBo Pharmaceuticals (NRBO) operate in?

NeuroBo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NeuroBo Pharmaceuticals Stock (NASDAQ: NRBO) stock price, news, charts, stock research, profile.

Open	$2.40
Close	-
Volume / Avg.	5.82K / 44.20K
Day Range	$2.37 - $2.42
52 Wk Range	2.08 - 6.75
Market Cap	$20.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.59%
Days to Cover	1

Recent News

NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

Avi Kapoor

NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success

NeuroBo says DA-1241 data shows improved liver fibrosis and additive hepatoprotective effects when combined with semaglutide.

Vandana Singh

Dow Jumps 250 Points; Honeywell Issues Weak Forecast

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&P 500 also rose, gaining, 0.87% to 4,887.70.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.40
Close	-
Volume / Avg.	5.82K / 44.20K
Day Range	$2.37 - $2.42
52 Wk Range	2.08 - 6.75
Market Cap	$20.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.59%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuroBo Pharmaceuticals (NRBO) stock?

You can purchase shares of NeuroBo Pharmaceuticals (NASDAQ:NRBO) through any online brokerage.

View our list of the best stock brokerages

Who are NeuroBo Pharmaceuticals (NRBO) competitors?

Other companies in NeuroBo Pharmaceuticals’s space includes: Curis (NASDAQ:CRIS), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Sensei Biotherapeutics (NASDAQ:SNSE).

What is the forecast, or price target, for NeuroBo Pharmaceuticals (NRBO) stock?

NeuroBo Pharmaceuticals has a consensus price target of $8.00.

What is the current price for NeuroBo Pharmaceuticals (NRBO)?

The stock price for NeuroBo Pharmaceuticals (NASDAQ: NRBO) is $2.42 last updated November 19, 2024 at 11:13 AM EST.

Does NeuroBo Pharmaceuticals (NRBO) pay a dividend?

There are no upcoming dividends for NeuroBo Pharmaceuticals.

When is NeuroBo Pharmaceuticals (NASDAQ:NRBO) reporting earnings?

NeuroBo Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is NeuroBo Pharmaceuticals (NRBO) going to split?

There is no upcoming split for NeuroBo Pharmaceuticals.

What sector and industry does NeuroBo Pharmaceuticals (NRBO) operate in?

NeuroBo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

NeuroBo Pharmaceuticals

NeuroBo Pharmaceuticals (NRBO) Forecast